Since 2004, the Publications Committee has been charged with developing and publishing various publications, including the SMFM Consult Series and the SMFM Clinical Guidelines series published in the American Journal of Obstetrics & Gynecology. The Publications Committee collaborates with other Societies and Colleges to develop joint publications and statements, as appropriate. The Committee plans topics, selects authors, and reviews each completed paper before it is submitted for an internal SMFM review process and then for publication. All Committee members have filed conflict of interest statements with SMFM. Any conflicts have been resolved through a process approved by the Executive Board. To facilitate transparency in SMFM's guideline development process, a brief overview of the key stages in development is provided here. Feedback for SMFM Publications is welcome at pubs@smfm.org
Maternal mortality and severe maternal morbidity, particularly among women of color, have increased in the United States. The leading medical causes of maternal mortality include cardiovascular disease, infection, and common obstetric complications such as hemorrhage and vary by timing relative to... Continue Reading
Although perinatal substance use disorders, particularly those that involve opioids, have become a major public health issue in the United States, comprehensive ,evidence-based guidance for the prevention and management of these disorders during pregnancy is lacking.Leaders in obstetric care,... Continue Reading
Reproductive planning is essential for all women and most important for those with complex health conditions or at high risk for complications. Pregnancy planning can allow these high-risk women the opportunity to receive preconception counseling, medication adjustment, and risk assessment related... Continue Reading
Because autoimmune conditions occur more often among women of childbearing age, continuation of these medications during pregnancy is often considered to optimize disease management in the woman and pregnancy outcomes, without placing the fetus at undue risk. Many commonly prescribed drugs can be... Continue Reading
There are medical indications in pregnancy for which there is evidence or expert opinion to support delivery versus expectant management in the early-term period. However, the risk of adverse outcomes is greater for neonates delivered in the early-term period compared with neonates delivered at 39... Continue Reading
Interpregnancy care aims to maximize a woman’s level of wellness not just in between pregnancies and during subsequent pregnancies, but also along her life course. Because the interpregnancy period is a continuum for overall health and wellness, all women of reproductive age who have been... Continue Reading
Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a... Continue Reading
Download PDF TAGS: fetal anomalies, transvaginal ultrasound, ultrasound, diagnostic CATEGORIES: Joint Publication Continue Reading
Polyhydramnios, or hydramnios, is an abnormal increase in the volume of amniotic fluid. Identification of polyhydramnios should prompt a search for an underlying etiology. Although most cases of mild polyhydramniosare idiopathic, the 2 most common pathologic causes are maternal diabetes mellitus... Continue Reading
Download PDF TAGS: infection, infections, Flu Vaccine, influenza CATEGORIES: SMFM Endorsed Partner Publication Continue Reading
Download PDF TAGS: hiv, delivery, labor and delivery complications, labor, immune disorder, immunology CATEGORIES: SMFM Endorsed Partner Publication Continue Reading
Download PDF CATEGORIES: Maternal Medical Complications, Administrative Continue Reading
